MIDAS Healthcare Solutions, Inc., the leading developer of technology-driven solutions to promote the safe use, storage, return, and disposal of controlled substances and other dangerous medications in hospitals and other healthcare institutions, announced today a $2 million investment from MCPC Healthcare Investment, LLC, the newly formed investment arm of Cleveland-based MCPC.

MIDAS Healthcare Solutions，Inc。是技术驱动解决方案的领先开发商，旨在促进医院和其他医疗机构安全使用，储存，退回和处置受控物质和其他危险药物，今天宣布MCPC Healthcare投资200万美元有限责任公司，这是基于克利夫兰的MCPC新成立的投资部门。

This investment makes MCPC the largest single external shareholder of MIDAS and will allow MIDAS to expand its product development efforts in preparation for the 2024 product rollout..

这项投资使MCPC成为MIDAS的最大单一外部股东，并将允许MIDAS扩大其产品开发工作，为2024年产品推出做准备。。

This investment comes as the healthcare industry continues to be plagued by the diversion of opioids and other dangerous medications, enabling caregivers with substance use disorders to endanger themselves, their colleagues, and their patients. Recent data suggest that 1 in 100 healthcare workers diverts drugs in the clinical setting, although industry leaders acknowledge that the actual figure is likely substantially higher..

这项投资是因为医疗保健行业继续受到阿片类药物和其他危险药物转移的困扰，使患有物质使用障碍的护理人员能够危及自己，同事和患者。最近的数据显示，每100名医护人员中就有1人在临床环境中转移药物，尽管行业领导者承认实际数字可能会高得多。。

“As a former hospital pharmacy assistant director, I saw firsthand how healthcare providers can easily divert medications for their own use, which can lead to significant harm to themselves and the patients they serve,” said serial entrepreneur Michael LaFauci, RPh, Founder and CEO at MIDAS. “This new investment will allow us to expedite the deployment of the MIDAS VIEW system to eliminate opportunities for diversion while providing a system of accountability.

连续企业家迈克尔·拉法奇（Michael LaFauci）RPh创始人兼首席执行官说：“作为前医院药房助理总监，我第一手看到医疗保健提供者如何轻松转移药物供自己使用，这可能会对自己和他们所服务的患者造成重大伤害。”MIDAS。“这项新投资将使我们能够加快部署MIDAS VIEW系统，消除转移机会，同时提供问责制度。

It’s time we protect our healthcare providers and our patients.”.

现在是时候保护我们的医疗服务提供者和患者。”。

The first product to be marketed by MIDAS, the Verified Institutional Environment for Wasting (V.I.E.W.) is a small dedicated workstation for the safe and responsible handling of excess medication not needed for patient administration. The V.I.E.W. enables a more efficient, verified method of “wasting” excess inventory using several unique features: high-acuity camera and scanning technology, a video queue process that eliminates the immediate need to source an in-person witness to observe the process, and the ability to sequester samples for additional analysis..

第一个由MIDAS销售的产品，经过验证的浪费机构环境（V.I.E.W.）是一个小型专用工作站，用于安全和负责任地处理患者管理不需要的过量药物。V.I.E.W.提供了一种更有效、经过验证的方法，利用几个独特的功能“浪费”多余的库存：高敏度相机和扫描技术，视频队列过程，无需立即找到亲自见证人来观察这一过程，以及隔离样本进行额外分析的能力。。

MCPC is an information technology company that helps businesses manage the security risks and logistical challenges inherent in the use of a fleet of technology assets. It is a global endpoint management firm that works with its partners to improve user productivity, enhance data security, mitigate risks, and maximize budgets..

MCPC是一家信息技术公司，可帮助企业管理使用技术资产群所固有的安全风险和后勤挑战。它是一家全球端点管理公司，与其合作伙伴合作，提高用户生产力，增强数据安全性，降低风险并最大限度地提高预算。。

“This collaboration is a win-win for MIDAS and MCPC and will catalyze substantial growth for both companies,” said Mike Trebilcock, MCPC Founder and CEO. “We are proud to become a significant investor in MIDAS and look forward to helping deliver this groundbreaking product in early 2024.”

MCPC创始人兼首席执行官Mike Trebilcock说：“这项合作是MIDAS和MCPC的胜利，将促进两家公司的大幅增长。“我们很自豪成为MIDAS的重要投资者，并期待在2024年初帮助实现这一突破性产品。”

MIDAS will soon begin piloting the V.I.E.W. system at a number of tertiary care adult hospitals and a leading children’s hospital to demonstrate the value of increased medication security, validation and verification of witnessed wasting events, and increased operational efficiencies.

MIDAS将很快开始在一些三级医疗成人医院和一家领先的儿童医院试用V.I.W.系统，以展示增加药物安全性，验证和验证目击浪费事件以及提高运营效率的价值。

In recognition of this investment, Bryan Scheetz, MCPC’s Director of Healthcare & Enterprise Solutions, will join the MIDAS Board of Directors. Additionally, Mike Trebilcock and Ira Grossman, Chief Technology Officer at MPCP, will join the MIDAS Advisory Board. The advisory board is composed of leading experts from healthcare, pharmacy, business, government, and health IT.

鉴于这项投资，MCPC医疗保健与企业解决方案总监Bryan Scheetz将加入MIDAS董事会。此外，MPCP首席技术官Mike Trebilcock和Ira Grossman将加入MIDAS顾问委员会。咨询委员会由医疗保健，药房，商业，政府和卫生IT的领先专家组成。

Some of its notable members include Dr. Delos (Toby) Cosgrove (former CEO at the Cleveland Clinic), a former administrator at the Drug Enforcement Administration, the former CEO at the American Nurses Association, the former CEO at the American Pharmacists Association, and the former CEO at Stericycle..

其一些着名成员包括Delos博士（Toby）Cosgrove博士（克利夫兰诊所的前首席执行官），药品管理局的前管理员，美国护士协会的前首席执行官，美国药剂师协会的前首席执行官，以及Stericycle的前首席执行官。。

About MIDAS

关于迈达斯

Medication Integrity Diversion Accountability System (or MIDAS) creates software and other solutions to address failures in medication security which enable rising levels of medication diversion throughout healthcare. MIDAS’s mission is to promote and enable the safer use, handling, storage, return, and disposal of transdermal patches, injectables, and oral medications in healthcare institutions, pharmacies, and in the home.

药物完整性转移问责系统（或MIDAS）创建软件和其他解决方案来解决药物安全方面的故障，从而使整个医疗保健中的药物转移水平不断提高。MIDAS的使命是促进和实现医疗机构，药房和家庭中透皮贴剂，注射剂和口服药物的更安全使用，处理，储存，返回和处置。

Its solutions have attracted attention from government leaders, medical organizations, and industry leaders. Learn more by visiting midashs.com..

其解决方案引起了政府领导人，医疗机构和行业领导者的关注。通过访问midashs.com了解更多信息。。

About MCPC

关于MCPC

We’re the Outcome Engineers. MCPC is a global endpoint management company founded in 2002. Our approach inspires not just endpoint defense, but business offense. By protecting your devices, bringing simplicity to endpoint management complexity, and empowering employee performance, we reduce your business risk and increase digital innovation.

我们是成果工程师。MCPC是一家成立于2002年的全球端点管理公司。我们的方法不仅激发终点防御，而且激发商业犯罪。通过保护您的设备，简化端点管理复杂性并增强员工绩效，我们可以降低您的业务风险并增加数字创新。

Our consultative approach creates a true partnership where your endpoints are just the starting point..

我们的咨询方法创建了一个真正的伙伴关系，您的终点只是起点。。

Originally announced October 25th, 2023

最初于2023年10月25日宣布

TagsBryan Scheetz Dr. Delos (Toby) Cosgrove Health IT Funding Health IT Fundings Health IT Investment Ira Grossman MCPC MCPC Healthcare Investment Michael Lafauci Midas MIDAS Healthcare Solutions Mike Trebilcock

TagsBryan Scheetz Dr.Delos（Toby）Cosgrove Health IT资助健康IT资助健康IT投资Ira Grossman MCPC MCPC医疗保健投资Michael Lafauci Midas Midas医疗保健解决方案Mike Trebilcock

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入数千名订阅我们每日通讯的医疗保健和健康同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不会出售或提供您的联系信息